UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38594 TILRAY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 82-4310622 (State or other jurisdiction of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38594 TILRAY, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 82-4310622 (State or other jurisdiction of in ...

Tilray, Inc. (NASDAQ:TLRY) Q1 2022 Earnings Conference Call October 7, 2021 8:30 AM ET Company Participants Irwin Simon – Chairman and Chief Executive Officer Carl Merton – Chief Financial Officer Berrin Noorata – Chief Corporate Affairs Officer Conference Call Participants Owen Bennett – Jefferies Vivien Azer – Cowen and Company Andrew Carter – Stifel John Zamparo – CIBC World Markets Michael Lavery – Piper Sandler Aaron Grey – Alliance Global Partners Pablo Zuanic – Cantor Fitzgerald Glenn Mattson – Laden ...

INVESTOR PRESENTATION LEADING THE GLOBAL CANNABIS INDUSTRY JULY 2021 ATILRAY DISCLAIMER 2021© TILRAY | Certain statements contained in this press release constitute "forward-looking statements" within the meaning of federal securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictions based on expectations and projections about future events and are not statements of historical fact. You can identify forward-looking statements by the use of forwa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended May 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-38594 TILRAY, INC. (Exact name of Registrant as specified in its Charter) Delaware 82-4310622 (State or other jurisdiction of incorporatio ...

Financial Data and Key Metrics Changes - Net income rose to $33.6 million compared to a net loss of $84.3 million in the prior year [56][71] - Net revenue increased 25.3% to $142.2 million in Q4 over the prior year period [61] - Adjusted EBITDA increased to $40.8 million compared to $5.8 million in 2020, reflecting an improvement of 603% [76] - Free cash flow of $3.3 million was generated in Q4, marking a significant milestone for the company [56][73] Business Line Data and Key Metrics Changes - Cannabis revenue in Q4 was $53.7 million, up from $39.6 million in the same period of the prior year [61] - SweetWater's net revenues were $15.9 million, while Manitoba Harvest generated $5.8 million in essentially one month of activity [61] - Adjusted cannabis gross profit increased to $23.9 million in Q4 compared to $18.9 million in the prior year [64] - Adjusted beverage alcohol gross profit was $10.6 million in Q4, with a gross margin of 66.5% [68] Market Data and Key Metrics Changes - The average gross selling price of adult-use cannabis decreased to $2.98 per gram in Q4 from $3.90 per gram in the prior year [62] - The average gross selling price of medical cannabis decreased to $4.54 per gram in Q4 from $4.95 in the prior year [63] - The Canadian market share is currently at 16%, with a goal to reach 30% by fiscal year 2024 [16] Company Strategy and Development Direction - The company aims to achieve $4 billion in revenue by 2024, driven by growth in adult-use, medical cannabis, and new product offerings [8][84] - Strategic partnerships and strong relationships with provincial boards and retail partners are emphasized to drive brand loyalty and growth in Canada [19] - The company plans to leverage its international presence, particularly in Europe, to grow its medical cannabis business [30] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to execute on growth opportunities despite challenges posed by COVID-19 [10][11] - The reopening of markets is expected to improve sales dynamics, particularly for SweetWater [100] - Management highlighted the importance of consumer education and marketing changes in Canada to drive market share growth [95] Other Important Information - The company has a strong cash position of $488 million as of May 31, 2021, to support working capital and business plans [11][75] - The company has already achieved $35 million in synergies from the business combination, ahead of the anticipated pace [57][45] - The company is positioned to benefit from potential U.S. federal legalization, with plans to explore acquisitions in the consumer goods sector [84][104] Q&A Session Summary Question: Will there be permits issued to Tilray for continued growth and production in Germany? - Management confirmed that there are opportunities for additional tenders and production in Germany, especially with potential legalization from the Green Party [82] Question: Will SweetWater THC drinks be available in Canada, and are there plans to expand SweetWater to California? - Management stated that THC drinks will be available in Canada and that expansion into California is planned with a new facility in Fort Collins, Colorado [83] Question: How will Tilray benefit from pending federal legalization in the U.S.? - Management highlighted plans to grow through adult-use and medical cannabis, aiming for significant sales growth in the U.S. market post-legalization [84] Question: How is the company thinking about U.S. assets moving forward? - Management indicated a focus on acquiring consumer goods assets and MSOs, with a goal of achieving $1 billion to $1.5 billion in sales in the U.S. market [89][90] Question: What underpins the logic behind the 30% market share aspiration for 2024? - Management emphasized the need for increased consumer awareness, store openings, and innovation in products to achieve the market share goal [92][94]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38594 Tilray, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 82-4310622 (State or other jurisdiction of inc ...

Aphria Inc. (APHA) Q3 2021 Earnings Conference Call April 12, 2021 9:00 AM ET Company Participants Carl Merton - Chief Financial Officer Irwin Simon - Chief Executive Officer Conference Call Participants Owen Bennett - Jefferies Andrew Carter - Stifel Financial Tamy Chen - BMO Capital Markets Aaron Gray - Alliance Global Partners Pablo Zuanic - Cantor Fitzgerald John Zamparo - CIBC World Markets Matthew Bottomley - Canaccord Genuity Michael Lavery - Piper Sandler Operator Good morning. My name is Mariama a ...

(Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-38594 TILRAY, INC. (Exact name of Registrant as specified in its Charter) (State or other jurisdiction of incorporation or organizati ...

Tilray, Inc. (NASDAQ:TLRY) Q4 2020 Earnings Conference Call February 17, 2021 5:00 PM ET Company Participants Raphael Gross - Investor Relations Brendan Kennedy - Chief Executive Officer Michael Kruteck - Chief Financial Officer Conference Call Participants Tamy Chen - BMO Capital Markets Aaron Grey - Alliance Global Partners Rupesh Parikh - Oppenheimer Steve Schneiderman - Cowen and Company Pablo Zuanic - Cantor Fitzgerald Michael Lavery - Piper Jaffray Operator Greetings, and welcome to Tilray's Fourth Qu ...